EX-23.1 6 y50301exv23w1.htm EX-23.1: CONSENT OF DELOITTE & TOUCHE LLP EX-23.1
 

EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Nos. 33-73696, 33-73698, 333-17349, 333-17351, 333-50356, 333-75388, 333-75390, 333-102070, 333-102072 and 333-144210 of Barr Pharmaceuticals, Inc., formerly Barr Laboratories, Inc., (the “Company”), on Form S-8 of our reports dated February 29, 2008 relating to (1) the financial statements and financial statement schedule of the Company as of December 31, 2007 and 2006 and for the year ended December 31, 2007, the six month period ended December 31, 2006 and the years ended June 30, 2006 and 2005 (which report expresses an unqualified opinion and includes an explanatory paragraph regarding the adoption of Statement of Financial Accounting Standard No. 123(R), Share-Based Payment) and (2) the effectiveness of the Company’s internal control over financial reporting as of December 31, 2007, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2007.
/s/ Deloitte & Touche LLP
Parsippany, New Jersey
February 29, 2008